Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLosing weight fast on Wegovy comes down to three things working together: consistent weekly injections at the right dose, a real reduction in calorie intake, and enough physical activity to preserve muscle while fat comes off. Semaglutide suppresses appetite significantly, but it does not replace the habits that determine how much of that suppressed appetite you actually act on. These are prescription-only medicines, and a prescriber decides whether Wegovy is clinically suitable for you before treatment begins. What follows is a practical, evidence-based picture of the steps that genuinely shift the rate of progress for people on Wegovy.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing to accept on Wegovy is that the opening weeks are not your fastest weeks. Semaglutide begins at 0.25 mg, a tolerability dose designed to let your digestive system adjust, not to drive significant weight change. The dose rises roughly every four weeks through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance level. For most people that is around 16 weeks in. Weight loss typically accelerates once the maintenance dose is established and appetite suppression is at its fullest.
This is worth knowing because many people judge the medicine against those early, slower weeks and feel discouraged. The STEP 1 trial, published in the New England Journal of Medicine, followed participants for 68 weeks total and found an average reduction of around 15% body weight. The bulk of that loss came in the second half of the trial, after titration was complete. Expecting fast results in week two is the most common source of early frustration.
Your prescriber sets the titration schedule; it is not something to speed up unilaterally. If nausea or other gastrointestinal symptoms are significant, slowing down the increase is sometimes the right clinical call, even if it feels counterintuitive when you are eager to get moving. For a fuller look at the mechanism behind semaglutide's appetite effects, that context helps set realistic expectations from the start.
Wegovy reduces appetite reliably. The trap is assuming that eating less automatically means eating well. People on semaglutide often find they can manage on quite small amounts of food, and if those small amounts are low in protein and fibre, the body loses muscle alongside fat. Losing muscle slows your resting metabolic rate, which makes every subsequent week harder. That outcome is the opposite of losing weight fast in any meaningful sense.
Prioritising protein at each meal (eggs, fish, chicken, legumes, Greek yoghurt) alongside fibre-rich vegetables gives the body what it needs to preserve muscle while fat comes off. Hydration matters more than most people realise on GLP-1 medicines: nausea and reduced appetite can quietly reduce fluid intake, and mild dehydration blunts energy and can worsen side effects. The NHS semaglutide guidance recommends following dietary advice from your healthcare team throughout treatment.
Practical timing matters too. Some people find that keeping their injection day consistent (a Wednesday evening, say, rather than shifting it around payday or bank holidays) keeps the weekly rhythm steady and avoids accidental gaps that soften the medicine's effect. A missed or delayed dose is not a disaster, but a consistent schedule is one of the simplest things you can control. If you want more specific guidance on maximising weight loss on Wegovy, there is a dedicated page covering nutritional and activity strategies in more detail.
Semaglutide works on appetite and, to some extent, on metabolic signalling, and it is also worth being aware of how semaglutide interacts with cortisol, since stress hormones can influence both appetite and the rate at which weight comes off. It does not build muscle, improve cardiovascular fitness or increase the number of calories your body burns at rest. Those gains come from movement, and they compound the medicine's effect considerably.
Resistance training two or three times a week is the single most effective addition for people trying to lose weight fast on semaglutide, because it preserves and builds lean tissue while the medicine drives fat loss. Walking, cycling and swimming add calorie expenditure without placing significant stress on joints that may already be under pressure. The NHS England guidance on weight-management injections is clear that these medicines are licensed as an addition to, not a replacement for, reduced calorie intake and increased physical activity.
One caution worth naming: weight can come off quickly in the early maintenance-dose period, and that is generally welcome. But very rapid loss (more than about 1 kg per week over several consecutive weeks) can increase the risk of gallstones and muscle loss, and is worth discussing with your prescriber. There is a useful page on what losing weight too fast on Wegovy can mean clinically, and when it warrants a conversation.
Nausea, loose stools and constipation are the most commonly reported effects when starting or increasing the dose. They are also the most common reason people reduce their food intake below what is healthy, skip doses, or stop treatment before it has had time to work. Managing them actively keeps you on the trajectory that produces results.
Eating smaller portions, avoiding high-fat meals (which slow gastric emptying further), staying upright after eating and spacing meals evenly across the day all reduce severity. Cold or room-temperature food tends to trigger less nausea than hot food for some people. Ginger tea and plain crackers are low-risk additions. If symptoms are more than mild and transient, speak to your prescriber: there are clinical strategies available, and pushing through significant nausea alone is not the only option.
For context on the broader picture of how weight loss on Wegovy works, including what to expect month by month, that page covers the full arc from starting dose to maintenance. If you are considering whether Wegovy or tirzepatide suits your situation better, our weight-loss treatment overview sets out the licensed options plainly. Treatment is a prescription decision, and our prescribers review every application on the day it arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.